Revivegen Co., Ltd. (7578) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Revivegen Co., Ltd. stock TWD 7.91, price TWD 20.00, that is 60.5% below the price, quality 21 out of 100. Rating: strongly overvalued. Calculated from audited financials with 11 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 3, 2026.
How to read this chart
53‑month range 20.00 TWD – 49.82 TWD · fair‑value band 5.54 TWD – 10.28 TWD · the 20.00 TWD price screens above the 7.91 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 3, 2026.
Follow Revivegen Co. in your weekly email
Every Wednesday you see whether Revivegen Co. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Revivegen Co., Ltd. engages in the industrial waste treatment business in Taiwan.
Show moreShow less
It is involved in the waste solvent physical treatment and thermal treatment activities; and provision of semiconductor cleaning agent, chip cleaning agent, paint and coating additives, and lithium battery auxiliary materials.
Revivegen Co., Ltd. was founded in 2010 and is headquartered in Tainan City, Taiwan.
Stock analysis
Revivegen Co., Ltd. (7578) currently trades at 20.00 TWD, while our model-based Fair Value estimate is 7.91 TWD, 60% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Asset-Based group reads highest at a median of 16.76 TWD per share, and 1 of the 11 models we run sit above the 20.00 TWD price.
Bear case: the Earnings-Based group reads lowest at 5.34 TWD, and 10 of the 11 models stay below the price. Data coverage for this calculation is low.
Scenario range: 5.54 TWD (bear) to 10.28 TWD (bull), the price of 20.00 TWD sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 21/100 (below-average quality), in the Industrials sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revivegen Co., Ltd. reported revenue of 469M TWD in FY2025 versus 337M TWD in FY2021, a compound +8.6%/yr. Reported net income was 20.4M TWD in FY2025, compounding −13.0%/yr from FY2021.
Key figures
Market cap 1.2B TWD (≈ $36.6M) Micro · P/E ratio 66.7 · P/S ratio 2.39 · EPS (TTM) 0.3000 TWD · Dividend yield 1.7% · Net margin 3.6% · Return on equity −0.1% · Return on assets (EBIT) 1.6% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 25 out of 100 (medium confidence).
What moves the price
The share trades about 54% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Industrials peers we cover trades at −25% fair-value upside, at −60%, 7578 screens richer than that median.
Fair Value models
Bear5.54 TWDFair Value 7.91 TWDBull10.28 TWD
Price 20.00 TWD · Downside -60.5%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.52/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+4.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+11.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+19.0%
Start year 2020 (pandemic)
Revenue growth 7 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+21.8%
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in TWD ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis. Measured in TWD: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−18.9%
Earnings growth per share plus dividend.
Earnings per share, growth per year−20.6%
Dividend (yield on the price)1.7%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.9% → 7%
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Waste Management · 155 stocks
Beats the industry median on 2/12 measures
Overall it trails its industry peers.
Valuation
Quality Score21 · Bottom 25%
Fair Value upside−60.5% · Bottom 25%
Profitability
Return on assets0.3% · Below median
Net margin (12 months)3.6% · Below median
Operating margin (12 months)−1.6% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY)14.8% · Above median
Dividend yield (12 months)1.7% · Below median
Balance sheet
Debt / equity2.10× · Highest 25%
Valuation Multiplesvs Waste Management median · lower = cheaper
P/E (12 months)66.7× · Priciest 25%
P/B0.80× · Cheaper than median
P/S (12 months)2.39× · Pricier than median
EV/EBITDA29.7× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 35
FUTURE (revenue growth)74· sector 37
PAST (return on equity)0· sector 23
HEALTH (low debt)0· sector 83
DIVIDEND (yield)34· sector 52
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Revivegen Co., Ltd. (7578) overvalued or undervalued?
As of Nov 3, 2026, our model estimates a fair value of 7.91 TWD versus a price of 20.00 TWD, about 60% lower (overvalued).
What is the fair value of 7578?
Our model-based fair value for Revivegen Co., Ltd. is 7.91 TWD (as of Nov 3, 2026), built from audited fundamentals. The current price: 20.00 TWD.
What is the quality score of 7578?
Revivegen Co., Ltd. has a Quality Score of 21/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Revivegen Co., Ltd. (7578)?
Our model-based price target is the fair value of 7.91 TWD (as of Nov 3, 2026) from 11 valuation models. Cautious scenario 5.54 TWD, optimistic scenario 10.28 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the Revivegen Co., Ltd. stock forecast for 2026?
Our models put fair value at 7.91 TWD, about 60% lower versus a price of 20.00 TWD (overvalued). Cautious scenario 5.54 TWD, optimistic scenario 10.28 TWD. The calculation is refreshed regularly with new filings.
What is the revenue of Revivegen Co., Ltd. (7578)?
Revivegen Co., Ltd. reported trailing-twelve-month revenue of about 502M TWD (latest available figure, as of Nov 3, 2026).
Does Revivegen Co., Ltd. pay a dividend?
Revivegen Co., Ltd. currently shows a dividend yield of 1.70% relative to its recent price (as of Nov 3, 2026).
How much is the dividend of Revivegen Co., Ltd. (7578) and when is the ex-dividend date?
Revivegen Co., Ltd. pays a dividend of 0.339 TWD per share a year, a dividend yield of 1.7%. The last ex-dividend date was Jul 23, 2026. A dividend has been paid every year since at least 2022. The payout ratio is 113% of earnings. Our assessment: Pays more than it earns. The company pays out more in dividends than it earns, and free cash flow clearly does not cover the dividend either. It may need to be cut unless profits recover.
What is the intrinsic value of Revivegen Co., Ltd. (7578)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Revivegen Co., Ltd. it is 7.91 TWD per share (as of Nov 3, 2026), against a price of 20.00 TWD. It is the blended result of 11 valuation models in 6 families (Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is Revivegen Co., Ltd. stock overvalued or undervalued in 2026?
As of Nov 3, 2026, 7578 trades above its calculated fair value: price 20.00 TWD, fair value 7.91 TWD, a gap of about −60% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 7578?
No. The price is what the market pays today (20.00 TWD); the fair value is what the company's own numbers justify (7.91 TWD). For Revivegen Co., Ltd. the two are 12.09 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is Revivegen Co., Ltd. worth?
The market values Revivegen Co., Ltd. at about 1.2B TWD (market capitalisation, as of Nov 3, 2026). Per share that is 20.00 TWD; our models calculate a fair value of 7.91 TWD per share.
What do the bullish and bearish scenarios say about 7578?
Our models span a range for Revivegen Co., Ltd.: cautious scenario 5.54 TWD, base 7.91 TWD, optimistic 10.28 TWD per share (as of Nov 3, 2026, price 20.00 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 7578?
Revivegen Co., Ltd. trades at a price-to-earnings ratio of 66.7 (as of Nov 3, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 7.91 TWD is built from several models across several years. Other multiples: P/B 0.8, P/S 2.4, EV/EBITDA 29.7.
How solid is the balance sheet of Revivegen Co., Ltd. (7578)?
Balance-sheet figures for Revivegen Co., Ltd. (as of Nov 3, 2026): return on equity −0.1%, debt of 2.10 per unit of equity. They feed the Quality Score of 21/100, which measures business quality independently of the share price.
How far is 7578 from its 52-week high?
Revivegen Co., Ltd. trades at 20.00 TWD, about 54% below its 52-week high of 43.17 TWD and at the low of 20.00 TWD (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 7.91 TWD is for.
Which stocks are comparable to Revivegen Co., Ltd.?
From the same area (Industrials) we also value Waste Management, Inc, Republic Services, Inc, Waste Connections, Inc, Veolia Environnement SA, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Revivegen Co., Ltd. stock attractive at the current price?
The data as of Nov 3, 2026: price 20.00 TWD, calculated fair value 7.91 TWD (−60%), Quality Score 21/100, from 11 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 7578 calculated?
We run Revivegen Co., Ltd. through 11 models from 6 families: Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 7.91 TWD builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Revivegen Co., Ltd. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Revivegen Co., Ltd. (7578)?
The closing price on Nov 6, 2026 was 20.00 TWD. Our model-based fair value is 7.91 TWD, about 60% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Revivegen Co., Ltd. right now?
The price sits above even our optimistic bull case (10.28 TWD). The favourable scenario is already priced in. Weak quality (21/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (5.54 TWD to 10.28 TWD) leaves room in how you read the outcome.
Key figures of Revivegen Co., Ltd.
How large is the market capitalisation of Revivegen Co., Ltd. (7578)?
The market capitalisation of Revivegen Co., Ltd. is 1.2B TWD (≈ $36.6M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Revivegen Co., Ltd. (7578)?
The price-to-sales ratio of Revivegen Co., Ltd. is 2.39 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Revivegen Co., Ltd. (7578)?
Earnings per share at Revivegen Co., Ltd. are 0.3000 TWD (price ÷ EPS = P/E 66.7). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Revivegen Co., Ltd. (7578)?
The dividend yield of Revivegen Co., Ltd. is 1.7% (payout 113%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Revivegen Co., Ltd. (7578)?
The net margin of Revivegen Co., Ltd. is 3.6% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Revivegen Co., Ltd. (7578)?
The return on equity (ROE) of Revivegen Co., Ltd. is −0.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Revivegen Co., Ltd. (7578)?
On an EBIT basis the return on assets of Revivegen Co., Ltd. is 1.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Revivegen Co., Ltd. (7578)?
The operating margin of Revivegen Co., Ltd. is −1.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Revivegen Co., Ltd. (7578)?
Revenue at Revivegen Co., Ltd. is growing +14.8% versus a year earlier (3y avg +11.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Revivegen Co., Ltd. (7578)?
Earnings per share at Revivegen Co., Ltd. are growing −57.1% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Revivegen Co., Ltd. (7578) generate?
The free cash flow of Revivegen Co., Ltd. is −1.2B TWD (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Revivegen Co., Ltd. (7578) carry?
The net debt of Revivegen Co., Ltd. is 3.2B TWD (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Revivegen Co., Ltd. in the live analysis
One click puts Revivegen Co., Ltd. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 3, 2026